Enhanced metabolic health and immune response with bictegravir/emtricitabine/TAF: Insights from a 96‑week retrospective study.
Spampinato S, Conti GN, Marino A, Raimondo V, Celesia BM, Pellicanò GF, Puci MV, Sotgiu G, Bruno R, Villari N, Mirabile A, Coco VAM, Paternò Raddusa MS, Pistarà E, Boscia V, Fisicaro V, Fiorenza G, Cacopardo B, Rullo EV, Nunnari G.
Spampinato S, et al.
Biomed Rep. 2024 Oct 2;21(6):179. doi: 10.3892/br.2024.1867. eCollection 2024 Dec.
Biomed Rep. 2024.
PMID: 39387001
Free PMC article.